PreprintCited by 710PI3K/AKT/mTOR signaling in cancerCancer, Hypoxia, and MetabolismTuberous Sclerosis Complex Research

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling

Open access

DeYoung, Maurice Phillip, Horak, Peter, Sofer, Avi, Sgroi, Dennis, Ellisen, Leif W.·2008·Genes & Development

DOI 10.1101/gad.1617608PMC PMC2192757

Open this paper in CoChat — free account Open PDF

Abstract

Hypoxia induces rapid and dramatic changes in cellular metabolism, in part through inhibition of target of rapamycin (TOR) kinase complex 1 (TORC1) activity. Genetic studies have shown the tuberous sclerosis tumor suppressors TSC1/2 and the REDD1 protein to be essential for hypoxia regulation of TORC1 activity in Drosophila and in mammalian cells. The molecular mechanism and physiologic significance of this effect of hypoxia remain unknown. Here, we demonstrate that hypoxia and REDD1 suppress mammalian TORC1 (mTORC1) activity by releasing TSC2 from its growth factor-induced association with inhibitory 14–3–3 proteins. Endogenous REDD1 is required for both dissociation of endogenous TSC2/14–3–3 and inhibition of mTORC1 in response to hypoxia. REDD1 mutants that fail to bind 14–3–3 are defective in eliciting TSC2/14–3–3 dissociation and mTORC1 inhibition, while TSC2 mutants that do not bind 14-3-3 are inactive in hypoxia signaling to mTORC1. In vitro, loss of REDD1 signaling promotes proliferation and anchorage-independent growth under hypoxia through mTORC1 dysregulation. In vivo, REDD1 loss elicits tumorigenesis in a mouse model, and down-regulation of REDD1 is observed in a subset of human cancers. Together, these findings define a molecular mechanism of signal integration by TSC1/2 that provides insight into the ability of REDD1 to function in a hypoxia-dependent tumor suppressor pathway.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.1617608

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,590
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
Self-citation
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J., van de Rijn, M., Bair, E., Montgomery, K. D., Ferrari, M. K., Egevad, L., Rayford, W., Bergerheim, U. S. R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,282

Flagged first, then by citations

Show all 41 references

Sorted by citations

Items 101–200 of 710

The role of mTOR in the management of solid tumors: An overview
Strimpakos, A. S., Karapanagiotou, E. M., Saif, M. W., & Syrigos, K. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.006 · Cited by 163
REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling
Dennis, M. D., Coleman, C. S., Berg, A., Jefferson, L. S., & Kimball, S. R. (2014) · Science Signaling · doi:10.1126/scisignal.2005103 · Cited by 159
Autophagy as a target for cancer therapy: new developments
Nawrocki, S. T., Carew, & Kelly, K. (2012) · Cancer Management and Research · doi:10.2147/cmar.s26133 · Cited by 156
mTORC1 pathway in DNA damage response
Ma, Y., Vassetzky, Y. S., & Dokudovskaya, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.06.011 · Cited by 157
Autophagy in kidney disease and aging: lessons from rodent models
Lenoir, O., Tharaux, P., & Huber, T. B. (2016) · Kidney International · doi:10.1016/j.kint.2016.04.014 · Cited by 156
Mammalian Target of Rapamycin: Hitting the Bull′s‐Eye for Neurological Disorders
Chong, Z. Z., Shang, Y., Zhang, L., Wang, S., & Maiese, K. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.6.14787 · Cited by 149
The 14-3-3 proteins in regulation of cellular metabolism
Kleppe, R., Martı́nez, A., Døskeland, S. O., & Haavik, J. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.08.008 · Cited by 150
Cancer and mTOR Inhibitors in Transplant Recipients
de Fijter, J. W. (2016) · Transplantation · doi:10.1097/tp.0000000000001447 · Cited by 149
Overview of Research into mTOR Inhibitors
Mao, B., Zhang, Q., Ma, L., Zhao, D., Zhao, P., & Yan, P. (2022) · Molecules · doi:10.3390/molecules27165295 · Cited by 155
PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells
Bossler, F., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092188 · Cited by 149
mTORC1 signaling: what we still don't know
Wang, X., & Proud, C. G. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq038 · Cited by 150
Dietary intervention in acne
Melnik, B. C. (2012) · Dermato-Endocrinology · doi:10.4161/derm.19828 · Cited by 151
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Conciatori, F., Ciuffreda, L., Bazzichetto, C., Falcone, I., Pilotto, S., Bria, E., Cognetti, F., & Milella, M. (2018) · Cancers · doi:10.3390/cancers10010023 · Cited by 145
The Opposing Actions of Target of Rapamycin and AMP-Activated Protein Kinase in Cell Growth ControlPreprint
Hindupur, S. K., González, A., & Hall, M. N. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019141 · Cited by 147
mTOR signaling for biological control and cancer
Alayev, A., & Holz, M. K. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24351 · Cited by 143
Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment
Justus, C., Sanderlin, E. J., & Yang, L. V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511055 · Cited by 139
DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer
Tirado-Hurtado, I., Fajardo, W., & Pinto, J. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00106 · Cited by 134
SREBP: a novel therapeutic target
Xu, X., & Song, B. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms112 · Cited by 137
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis
Martelli, A. M., Evangelisti, C., Chiarini, F., Grimaldi, C., Cappellini, A., Ognibene, A., & McCubrey, J. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.04.005 · Cited by 134
REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A–DDB1 ubiquitin ligase
Katiyar, S., Liu, E., Knutzen, C. A., Lang, E. S., Lombardo, C. R., Sankar, S., Toth, J. I., Petroski, M. D., Ronai, Z., & Chiang, G. G. (2009) · The EMBO Reports · doi:10.1038/embor.2009.93 · Cited by 150
An emerging role for TOR signaling in mammalian tissue and stem cell physiology
Russell, R. C., Fang, C., & Guan, K. (2011) · Development · doi:10.1242/dev.058230 · Cited by 136
REDD1/Autophagy Pathway Is Associated with Neutrophil-Driven IL-1β Inflammatory Response in Active Ulcerative Colitis
Angelidou, I., Chrysanthopoulou, A., Mitsios, A., Arelaki, S., Αραμπατζιόγλου, Α., Kambas, K., Ritis, D., Tsironidou, V., Moschos, I., Dalla, V., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701643 · Cited by 128
Autophagy in Neutrophils: From Granulopoiesis to Neutrophil Extracellular Traps
Skendros, P., Mitroulis, I., & Ritis, K. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00109 · Cited by 132
The neurovascular unit and systemic biology in stroke — implications for translation and treatment
Tiedt, S., Buchan, A. M., Dichgans, M., Lizasoaín, I., Moro, M. Á., & Lo, E. H. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00703-z · Cited by 135
The role of hypoxia-inducible factor-2 in digestive system cancers
Zhao, J., Du, F., Shen, G., Zheng, F., & Xu, B. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.565 · Cited by 122
Control of Translation Initiation through Integration of Signals Generated by Hormones, Nutrients, and Exercise*
Kimball, S., & Jefferson, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.137208 · Cited by 122
Role of mTOR Signaling in Tumor Microenvironment: An Overview
Conciatori, F., Bazzichetto, C., Falcone, I., Pilotto, S., Bria, E., Cognetti, F., Milella, M., & Ciuffreda, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082453 · Cited by 131
Cell Cycle Regulation by the Nutrient-Sensing Mammalian Target of Rapamycin (mTOR) Pathway
Cuyàs, E., Corominas-Faja, B., Joven, J., & Menéndez, J. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0888-2_7 · Cited by 128
Chapter 3 Ribosomal Protein S6 Kinase
Meyuhas, O., & Dreazen, A. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)90003-5 · Cited by 131
The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging
Fernandes, S., & Demetriades, C. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.707372 · Cited by 131
Stress-mediated translational control in cancer cells
Leprivier, G., Rotblat, B., Khan, D., Jan, E., & Sorensen, P. H. B. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.11.002 · Cited by 132
Crosstalk between Apoptosis and Autophagy: Molecular Mechanisms and Therapeutic Strategies in Cancer
El‐Khattouti, A., Selimović, D., Haïkel, Y., & Hassan, M. (2013) · Journal of Cell Death · doi:10.4137/jcd.s11034 · Cited by 125
A Critical Kinase Cascade In Neurological Disorders: Pi3K, Akt and Mtor
Chong, Z. Z., Shang, Y., Wang, S., & Maiese, K. (2012) · Future Neurology · doi:10.2217/fnl.12.72 · Cited by 122
Metabolic-Stress-Induced Rearrangement of the 14-3-3ζ Interactome Promotes Autophagy via a ULK1- and AMPK-Regulated 14-3-3ζ Interaction with Phosphorylated Atg9
Weeresekara, V., Panek, D. J., Broadbent, D. G., Mortenson, J. B., Mathis, A. D., Logan, G., Prince, J. T., Thomson, D. M., Thompson, J. W., & Andersen, J. L. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00740-14 · Cited by 129
USP1 deubiquitinates Akt to inhibit PI3K‐Akt‐FoxO signaling in muscle during prolonged starvation
Goldbraikh, D., Neufeld, D., Eid‐Mutlak, Y., Lasry, I., Gilda, J. E., Parnis, A., & Cohen, S. (2020) · EMBO Reports · doi:10.15252/embr.201948791 · Cited by 126
Downregulation of Akt/Mammalian Target of Rapamycin Pathway in Skeletal Muscle Is Associated with Increased REDD1 Expression in Response to Chronic Hypoxia
Favier, F. B., Costes, F., Defour, A., Bonnefoy, R., Lefai, E., Baugé, S., Peinnequin, A., Benoit, H., & Freyssenet, D. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00550.2009 · Cited by 127
TGFβ-Stimulated MicroRNA-21 Utilizes PTEN to Orchestrate AKT/mTORC1 Signaling for Mesangial Cell Hypertrophy and Matrix Expansion
Dey, N., Ghosh‐Choudhury, N., Kasinath, B. S., & Choudhury, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042316 · Cited by 120
Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function
Fernández, J. P., Luddy, K. A., Harmon, C., & O’Farrelly, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174131 · Cited by 119
Regulation of mTORC1 Signaling by pH
Balgi, A. D., Diering, G. H., Donohue, E., Lam, K., Fonseca, B. D., Zimmerman, C., Numata, M., & Roberge, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021549 · Cited by 120
TOR signaling never gets old: Aging, longevity and TORC1 activity
Evans, D. S., Kapahi, P., Hsueh, W., & Kockel, L. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.04.001 · Cited by 118
Eukaryotic translation initiation factors as promising targets in cancer therapy
Hao, P., Yu, J., Ward, R. J., Liu, Y., Qiao, H., An, S., & Xu, T. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00607-9 · Cited by 127
mTOR Signaling in Parkinson’s Disease
Lan, A., Chen, J., Zhao, Y., Chai, Z., & Hu, Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8417-7 · Cited by 117
Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication
Kuss-Duerkop, S. K., Wang, J., Mena, I., White, K. M., Metreveli, G., Sakthivel, R., Mata, M. A., Muñoz-Moreno, R., Chen, X., Krammer, F., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006635 · Cited by 110
Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury
Birtwistle, L., Chen, X.-M., & Pollock, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126596 · Cited by 113
REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy
Britto, F. A., Begue, G., Rossano, B., Docquier, A., Vernus, B., Sar, C., Ferry, A., Bonnieu, A., Ollendorff, V., & Favier, F. B. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00234.2014 · Cited by 112
A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73
Rosenbluth, J. M., Mays, D. J., Pino, M. F., Tang, L. J., & Pietenpol, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00305-08 · Cited by 114
Activating transcription factor 4 and CCAAT/enhancer-binding protein-β negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress
Jin, H., Seo, S., Woo, S., Kim, E. S., Lee, H., Yoo, D., An, S., Choe, T., Lee, S., Hong, S., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.015 · Cited by 113
Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma
Kucejová, B., Peña‐Llopis, S., Yamasaki, T., Sivanand, S., Tran, T. A. T., Alexander, S., Wolff, N. C., Lotan, Y., Xie, X.-J., Kabbani, W., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0302 · Cited by 118
Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals
Tan, V. P., & Miyamoto, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.005 · Cited by 113
Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade
Maiese, K., Chong, Z. Z., Wang, S., & Shang, Y. C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131113830 · Cited by 109
Current mechanistic insights into the CCCP-induced cell survival response
Kane, M. S., Paris, A., Codron, P., Cassereau, J., Procaccio, V., Lenaers, G., Reynier, P., & Chevrollier, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.018 · Cited by 115
Hypoxia-Induced Energy Stress Inhibits the mTOR Pathway by Activating an AMPK/REDD1 Signaling Axis in Head and Neck Squamous Cell Carcinoma
Schneider, A., Younis, R. H., & Gutkind, J. S. (2008) · Neoplasia · doi:10.1593/neo.08586 · Cited by 107
The mTORC1 signaling repressors REDD1/2 are rapidly induced and activation of p70S6K1 by leucine is defective in skeletal muscle of an immobilized rat hindlimb
Kelleher, A. R., Kimball, S. R., Dennis, M. D., Schilder, R. J., & Jefferson, L. S. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2012 · Cited by 111
The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
Cui, D., Qu, R., Liu, D., Xiong, X., Liang, T., & Zhao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.775507 · Cited by 112
DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways
Du, F., Sun, L., Chu, Y., Li, T., Lei, C., Wang, X., Jiang, M., Min, Y., Lu, Y., Zhao, X., et al. (2018) · Cancer Communications · doi:10.1186/s40880-018-0315-y · Cited by 103
Cellular and molecular effects of the mTOR inhibitor everolimus
Saran, U., Foti, M., & Dufour, J. (2015) · Clinical Science · doi:10.1042/cs20150149 · Cited by 111
Signaling pathways and mechanisms of hypoxia‐induced autophagy in the animal cells
Fang, Y., Tan, J., & Zhang, Q. (2015) · Cell Biology International · doi:10.1002/cbin.10463 · Cited by 105
Elevated Corticosterone Associated with Food Deprivation Upregulates Expression in Rat Skeletal Muscle of the mTORC1 Repressor, REDD1
McGhee, N. K., Jefferson, L. S., & Kimball, S. R. (2009) · Journal of Nutrition · doi:10.3945/jn.108.099846 · Cited by 111
Regulated in Development and DNA Damage Response 1 Deficiency Impairs Autophagy and Mitochondrial Biogenesis in Articular Cartilage and Increases the Severity of Experimental Osteoarthritis
Álvarez-García, Ó., Matsuzaki, T., Olmer, M., Plate, L., Kelly, J. W., & Lotz, M. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40104 · Cited by 101
The Role of Hypoxia in Glioblastoma Radiotherapy Resistance
Chédeville, A. L., & Madureira, P. A. (2021) · Cancers · doi:10.3390/cancers13030542 · Cited by 101
Emerging Role of MicroRNAs in mTOR Signaling
Zhang, Y., Huang, B., Wang, H., Chang, A., & Zheng, X. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2485-1 · Cited by 100
Expression of growth-related genes in young and older human skeletal muscle following an acute stimulation of protein synthesis
Drummond, M. J., Miyazaki, M., Dreyer, H. C., Pennings, B., Dhanani, S., Volpi, E., Esser, K. A., & Rasmussen, B. B. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90842.2008 · Cited by 100
mTORC1 signaling governs hematopoietic stem cell quiescence
Gan, B., & DePinho, R. A. (2009) · Cell Cycle · doi:10.4161/cc.8.7.8045 · Cited by 99
Transcriptional regulation of the stress response by mTOR
Aramburu, J. F., Ortells, M. C., Vaquero, S. T., Buxadé, M., & López‐Rodríguez, C. (2014) · Science Signaling · doi:10.1126/scisignal.2005326 · Cited by 100
Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4
Knowles, L. M., Chen, Y., Osterman, A. L., & Smith, J. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803384200 · Cited by 100
Molecular mechanisms of mTOR regulation by stress
Heberle, A. M., Prentzell, M. T., van Eunen, K., Bakker, B. M., Grellscheid, S. N., & Thedieck, K. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.970489 · Cited by 102
Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin
Xu, J., Pham, C. G., Albanese, S. K., Dong, Y., Oyama, T., Lee, C., Rodrik-Outmezguine, V. S., Yao, Z., Han, S. I., Chen, D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86120 · Cited by 100
The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway
Zhang, Y., Liu, X., Wang, Y., Lai, S., Wang, Z., Yang, Y., Liu, W., Wang, H., & Tang, B. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01647-0 · Cited by 95
Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes
Molitoris, J. K., McColl, K. S., Swerdlow, S., Matsuyama, M., Lam, M., Finkel, T. H., Matsuyama, S., & Distelhorst, C. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.245423 · Cited by 96
Emerging therapies for Parkinson's disease: From bench to bedside
Tarazi, F. I., Sahli, Z. T., Wolny, M., & Mousa, S. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.05.010 · Cited by 106
Metabolite and transcriptome analysis during fasting suggest a role for the p53-Ddit4 axis in major metabolic tissues
Schupp, M., Chen, F., Briggs, E. R., Rao, S. J., Pelzmann, H. J., Pessentheiner, A. R., Bogner‐Strauß, J. G., Lazar, M. A., Baldwin, D. A., & Prokesch, A. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-758 · Cited by 103
TOR and ageing: a complex pathway for a complex process
McCormick, M. A., Tsai, S., & Kennedy, B. K. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0198 · Cited by 99
Short-Term Calorie Restriction in Male Mice Feminizes Gene Expression and Alters Key Regulators of Conserved Aging Regulatory Pathways
Estep, P. W., Warner, J. B., & Bulyk, M. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005242 · Cited by 91
TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1
Jin, H.-O., Seo, S.-K., Kim, Y.-S., Woo, S.-H., Lee, K.-H., Yi, J.-Y., Lee, S., Choe, T.-B., Lee, J.-H., An, S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.102 · Cited by 95
Frontier of Epilepsy Research - mTOR signaling pathway
Cho, C. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.5.032 · Cited by 93
Control of mTORC1 signaling by the Opitz syndrome protein MID1
Liu, E., Knutzen, C. A., Krauß, S., Schweiger, S., & Chiang, G. G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100131108 · Cited by 93
The mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis
Russo, E., Citraro, R., Constanti, A., & Sarro, G. D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8314-5 · Cited by 91
An mTORC1-GRASP55 signaling axis controls unconventional secretion to reshape the extracellular proteome upon stress
Nüchel, J., Tauber, M., Nolte, J. L., Mörgelin, M., Türk, C., Eckes, B., Demetriades, C., & Plomann, M. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.06.017 · Cited by 90
DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced Metaplasia
Miao, Z., Sun, J.-X., Adkins-Threats, M., Pang, M.-J., Zhao, J.-H., Wang, X., Tang, K.-W., Wang, Z.-N., & Mills, J. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.09.016 · Cited by 90
Size control: the developmental physiology of body and organ size regulation
Gokhale, R. H., & Shingleton, A. W. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.181 · Cited by 93
Intake of branched-chain amino acids influences the levels of MAFbx mRNA and MuRF-1 total protein in resting and exercising human muscle
Moberg, M., Apró, W., & Blomstrand, E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00353.2011 · Cited by 93
HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells
Marhold, M., Tomasich, E., El‐Gazzar, A., Heller, G., Spittler, A., Horvat, R., Krainer, M., & Horak, P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0153-t · Cited by 93
Self-citation
A Role for p38 Stress-Activated Protein Kinase in Regulation of Cell Growth via TORC1
Cully, M., Genevet, A., Warne, P. H., Treins, C., Liu, T., Bastien, J., Baum, B., Tapon, N., Leevers, S. J., & Downward, J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00688-09 · Cited by 89
Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner
Miloslavski, R., Cohen, E., Avraham, A., Iluz, Y., Hayouka, Z., Kasir, J., Mudhasani, R., Jones, S. N., Cybulski, N., Rüegg, M. A., et al. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju008 · Cited by 89
DEPTOR at the Nexus of Cancer, Metabolism, and Immunity
Caron, A., Briscoe, D. M., Richard, D., & Laplante, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00064.2017 · Cited by 87
Autophagy in hypoxic ovary
Yadav, A. K., Yadav, P. K., Chaudhary, G. R., Tiwari, M., Gupta, A., Sharma, A., Pandey, A. N., Pandey, A. K., & Chaube, S. K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03122-4 · Cited by 86
A novel cardioprotective p38-MAPK/mTOR pathway
Hernández, G., Lal, H., Fidalgo, M., Guerrero, A. T. G., Zalvide, J. B., Force, T. L., & Pombo, C. M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.09.011 · Cited by 88
mTORC1 senses stresses: Coupling stress to proteostasis
Su, K., & Dai, C. (2017) · BioEssays · doi:10.1002/bies.201600268 · Cited by 82
Suppression of replicative senescence by rapamycin in rodent embryonic cells
Pospelova, T. V., Leontieva, O. V., Bykova, T. V., Zubova, S. G., Pospelov, V. A., & Blagosklonny, M. V. (2012) · Cell Cycle · doi:10.4161/cc.20882 · Cited by 86
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
Samuel, S., Varghese, E., Kubatka, P., Triggle, C., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9120846 · Cited by 81
A Dedicated Evolutionarily Conserved Molecular Network Licenses Differentiated Cells to Return to the Cell Cycle
Miao, Z., Lewis, M. A., Cho, C. J., Adkins-Threats, M., Park, D., Brown, J. W., Sun, J.-X., Burclaff, J., Kennedy, S., Lu, J., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.005 · Cited by 85
Taking aim at Alzheimer's disease through the mammalian target of rapamycin
Maiese, K. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.941921 · Cited by 88
Cell-Type-Dependent Regulation of mTORC1 by REDD1 and the Tumor Suppressors TSC1/TSC2 and LKB1 in Response to Hypoxia
Wolff, N. C., Vega-Rubín-de-Celis, S., Xie, X., Castrillón, D. H., Kabbani, W., & Brugarolas, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01393-10 · Cited by 86
mTORC1‐ and mTORC2‐interacting proteins keep their multifunctional partners focused
Bracho‐Valdés, I., Moreno‐Alvarez, P., Valencia‐Martínez, I., Robles‐Molina, E., Chávez‐Vargas, L., & Vázquez‐Prado, J. (2011) · IUBMB Life · doi:10.1002/iub.558 · Cited by 84
Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin
Chong, Z. Z., Shang, Y. C., Wang, S., & Maiese, K. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.08.001 · Cited by 119
MALDI-Mass Spectrometric Imaging Revealing Hypoxia-Driven Lipids and Proteins in a Breast Tumor Model
Jiang, L., Chughtai, K., Purvine, S. O., Bhujwalla, Z. M., Raman, V., Paša‐Tolić, L., Heeren, R. M. A., & Glunde, K. (2015) · Analytical Chemistry · doi:10.1021/ac504503x · Cited by 81
Peroxisome Proliferator-Activated Receptors and Caloric Restriction—Common Pathways Affecting Metabolism, Health, and Longevity
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 86
Hormesis does not make sense except in the light of TOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100411 · Cited by 83
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
Foltyn‐Dumitru, M., Luger, A., Lorenz, N. I., Sauer, B., Mittelbronn, M. G. A., Harter, P. N., Steinbach, J., & Ronellenfitsch, M. W. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0368-3 · Cited by 78
Autophagy Paradox of Cancer: Role, Regulation, and Duality
Verma, A. K., Bharti, P. S., Rafat, S., Bhatt, D., Goyal, Y., Pandey, K. K., Ranjan, S. K., Almatroodi, S. A., Alsahli, M. A., Rahmani, A. H., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8832541 · Cited by 78

Authors: DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W.
Affiliations: Harvard University (US)
ORCID: DeYoung, Maurice Phillip
Horak, Peter
Sgroi, Dennis
Ellisen, Leif W.
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2008-01-15
Volume: 22
Issue: 2
Pages: 239-251
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.1617608
PMC: PMC2192757
OpenAlex: W2130396048
Cited by: 710
References: 41
Citations by year: 2026: 24 · 2025: 26 · 2024: 17 · 2023: 32 · 2022: 37 · 2021: 43 · 2020: 34 · 2019: 38 · 2018: 41 · 2017: 42 · 2016: 44 · 2015: 42 · 2014: 48 · 2013: 45 · 2012: 47
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA122589)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Keywords: hypoxia, TSC1/2, mTORC1, REDD1, 14-3-3 proteins, TORC1 inhibition, tumor suppression, anchorage-independent growth, carcinogenesis, cellular metabolism, signal integration
MeSH terms: Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Animals, Breast Neoplasms, Cells, Cultured, Humans, Mice, Nude, Models, Biological, Neoplasm Transplantation, Protein Kinases, Transcription Factors, Signal Transduction, Cell Hypoxia, Tumor Suppressor Proteins, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks